Plasma enalapril levels and hormonal effects after short‐ and long‐term administration in essential hypertension.
Open Access
- 1 April 1984
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 18 (S2) , 233S-241S
- https://doi.org/10.1111/j.1365-2125.1984.tb02602.x
Abstract
Enalapril lowers blood pressure both acutely and during long-term therapy in patients with essential hypertension. After a single 10 mg dose of enalapril a close relationship between plasma enalaprilic acid (MK-422) levels, angiotensin converting enzyme (ACE) inhibition and the acute hypotensive and hormonal effects was demonstrated. During long- term administration of enalapril, a similar relationship between the plasma enalaprilic acid level, ACE inhibition and the hypotensive effect was shown, although the dose-response curve for plasma enalaprilic acid to ACE inhibition was displaced to the right compared to the acute dose-response curve. Several weeks' administration of enalapril was needed to reach stable plateau levels of plasma enalaprilic acid and ACE inhibition. During long-term treatment with enalapril in essential hypertension, there was sustained inhibition of ACE and the associated hormonal changes.Keywords
This publication has 29 references indexed in Scilit:
- Angiotensin-Converting Enzyme Inhibitors in the Treatment of HypertensionDrugs, 1984
- Mechanism for Hypotensive Action of Angiotensin Converting Enzyme InhibitorsClinical and Experimental Hypertension. Part A: Theory and Practice, 1984
- Enzymes of the Renin-Angiotensin System and their InhibitorsAnnual Review of Biochemistry, 1982
- CaptoprilNew England Journal of Medicine, 1982
- CaptoprilDrugs, 1980
- Captopril compared with other antirenin system agents in hypertensive patients: its triphasic effects on blood pressure and its use to identify and treat the renin factor.Hypertension, 1980
- Clinical use of an orally acting converting enzyme inhibitor: captopril.Hypertension, 1980
- LONG-TERM EFFECTS OF CAPTOPRIL (SQ14 225) ON BLOOD-PRESSURE AND HORMONE LEVELS IN ESSENTIAL HYPERTENSIONThe Lancet, 1979
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977